Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review
Open Access
- 18 October 2021
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 10 (1), 159-163
- https://doi.org/10.14218/jcth.2021.00176
Abstract
Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, is known for its grim prognosis, with untreated life expectancy being only a matter of months after the diagnosis. The difficulty in making a diagnosis early is one of the main contributing factors to the poor prognosis. Alpha-fetoprotein (AFP) had long been used as a surveillance tool, but suboptimal specificity and sensitivity has prompted liver societies to abandon the recommendation for its universal use, even in combination with ultrasonography. Most studies have shown no obvious correlation between serum AFP level and HCC tumor size, stage, or survival post-diagnosis. However, some studies concluded that a gradual rise or persistent elevation in AFP were positive predictors for tumor development. Other studies reported a fall in AFP followed by a rise in patients with HCC as well as persistently rising AFP levels without development of HCC on follow up. Our calculation of the sensitivity and specificity of persistently rising AFP for HCC were both low, at 60% and 35.8%, respectively, indicating that the presence of persistently rising AFP per se did not offer diagnostic benefit. In addition, our calculated mean slopes of persistently rising AFP levels in HCC and non-HCC patients were numerically very different, but the difference was not statistically significant. We conclude that the published data do not support a role for rising AFP levels per se in the diagnosis of HCC.Keywords
This publication has 28 references indexed in Scilit:
- Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in JapanEuropean Journal of Cancer Prevention, 2009
- Diagnosis of hepatocellular carcinomaHPB, 2005
- Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adultsGut, 2003
- α-fetoprotein monitoring in chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinomaJournal of Hepatology, 1989
- Early recognition of hepatocellular carcinomaJournal of Hepatology, 1986
- Alpha‐fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinomaLiver International, 1986
- Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.Journal of Clinical Pathology, 1977
- Structure and Function of Alpha-FetoproteinAnnual Review of Medicine, 1977
- Alpha-fetoprotein in primary liver cancer and other diseases.Gut, 1974
- Serum alpha-fetoprotein levels in acute viral hepatitisGut, 1973